CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma

Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binneboesel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann*, Tom Luedde*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Web of Science)
Original languageEnglish
Article number16975
Number of pages10
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 5 Dec 2017

Keywords

  • PRIMARY SCLEROSING CHOLANGITIS
  • CARBOHYDRATE ANTIGEN 19-9
  • INTRAHEPATIC CHOLANGIOCARCINOMA
  • PERIHILAR CHOLANGIOCARCINOMA
  • HILAR CHOLANGIOCARCINOMA
  • SURGICAL RESECTION
  • SERUM CA19-9
  • DIAGNOSTIC-ACCURACY
  • COLORECTAL-CANCER
  • ALPHA-FETOPROTEIN

Cite this